Immune signalling Archives - Page 15 of 15 - Inside Precision Medicine

Inside Precision Medicine 23andMe Inks Monoclonal Antibody Deal for Inflammatory Disease Therapeutic Development

23andMe has raised an additional $250 million in growth financing

News & Features

23andMe Inks Monoclonal Antibody Deal for Inflammatory Disease Therapeutic Development

January 13, 2020

T-cells attacking cancer cell illustration of microscopic photos

News & Features

Cellectis Reports Proof-of-Concept for “Smart” CAR T-Cells

November 15, 2019

Introduction to Cell Therapy

News & Features

Introduction to Cell Therapy

November 5, 2019

Secondary tuberculosis infection, illustration

News & Features

Genetic Susceptibility to Tuberculosis Uncovered

January 3, 2019

NanoView Biosciences has closed on a $10 million Series B financing

News & Features

NanoView Plans Platform Development, Launch with $10M Series B Financing

October 12, 2018

Lung cancer, artwork

News & Features

Immunotherapy Biomarker Predicts Lung Cancer Response and Survival

June 12, 2018

Parkinson's disease nerve cells, illustration

News & Features

New Finding on Parkinson’s Disease Gene Mutation Upends View of Disease’s Cause

March 22, 2018

ChIP-Seq Spike-In Normalization Strategy

News & Features

ChIP-Seq Spike-In Normalization Strategy

September 7, 2016

1...13 1415Page 15 of 15

Related Content

MRI Technique Detects Pre-Malignant Pancreatic Cancer Lesions

MRI Technique Detects Pre-Malignant Pancreatic Cancer Lesions

Daratumumab Reduces Risk of Progression in High-Risk Smoldering Multiple Myeloma Patients

Daratumumab Reduces Risk of Progression in High-Risk Smoldering Multiple Myeloma Patients

The Importance of Increasing Diversity in Clinical Trials

The Importance of Increasing Diversity in Clinical Trials

UCSF Researchers Develop Precision Radiotherapy Approach for Cancer

UCSF Researchers Develop Precision Radiotherapy Approach for Cancer